Difference between revisions of "Pattabiraman DR, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 48 in DOI: 10.1038/s41392-020-0110-5 (Q9311)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Nat. Rev. Drug Discov., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): 497-512, #quickstatements; #temporary_batch_1590074839150) |
||
(2 intermediate revisions by the same user not shown) | |||
Property / Volume | |||
+ | 13 | ||
Property / Volume: 13 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | Tackling the cancer stem cells:what challenges do they pose? (English) | ||
Property / title: Tackling the cancer stem cells:what challenges do they pose? (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 497-512 | ||
Property / Page(s): 497-512 / rank | |||
+ | Normal rank |
Latest revision as of 15:28, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Pattabiraman DR, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 48 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pattabiraman DR
0 references
Weinberg RA
0 references
2014
0 references
Nat. Rev. Drug Discov.
0 references
13
0 references
Tackling the cancer stem cells:what challenges do they pose? (English)
0 references
497-512
0 references